1OZ1
P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4-AZAINDOLE INHIBITOR
1OZ1 の概要
エントリーDOI | 10.2210/pdb1oz1/pdb |
分子名称 | Mitogen-activated protein kinase 14, 3-(4-FLUOROPHENYL)-2-PYRIDIN-4-YL-1H-PYRROLO[3,2-B]PYRIDIN-1-OL (3 entities in total) |
機能のキーワード | ser/thr protein kinase, transferase |
由来する生物種 | Homo sapiens (human) |
細胞内の位置 | Cytoplasm (By similarity): Q16539 |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 43054.02 |
構造登録者 | Lovejoy, B.,Villasenor, A.,Browner, M.,Dunten, P. (登録日: 2003-04-07, 公開日: 2003-09-23, 最終更新日: 2024-02-14) |
主引用文献 | Trejo, A.,Arzeno, H.,Browner, M.,Chanda, S.,Cheng, S.,Comer, D.D.,Dalrymple, S.A.,Dunten, P.,Lafargue, J.,Lovejoy, B.,Freire-Moar, J.,Lim, J.,Mcintosh, J.,Miller, J.,Papp, E.,Reuter, D.,Roberts, R.,Sanpablo, F.,Saunders, J.,Song, K.,Villasenor, A.,Warren, S.D.,Welch, M.,Weller, P.,Whiteley, P.E.,Zeng, L.,Goldstein, D.M. Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase. J.Med.Chem., 46:4702-4713, 2003 Cited by PubMed Abstract: Inhibition of the biosynthesis of proinflammatory cytokines such as tumor necrosis factor and interleukin-1 via p38 has been an approach toward the development of a disease modifying agent for the treatment of chronic inflammation and autoimmune diseases. The development of a new core structure of p38 inhibitors, 3-(4-fluorophenyl)-2-(pyridin-4-yl)-1H-pyrrolo[3,2-b] pyridine, is described. X-ray crystallographic data of the lead bound to the active site of p38 was used to guide the optimization of the series. Specific focus was placed on modulating the physical properties of the core while maintaining potent inhibition of p38. These efforts identified 42c as a potent inhibitor of p38, which also possessed the required physical properties worthy of advanced studies. PubMed: 14561090DOI: 10.1021/jm0301787 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.1 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード